## **Erase Meso Annual Report period ending 31[st] December 2024** **Registered Charity Number: 1183208 Registered Address: 4 Capern Road, London SW18 3EE** ## **Trustees During 2024** Paul Cook Appointed 1[st] May 2019 Richard Bath Appointed 1[st] May 2019 Wayne O’Neil Appointed 1[st] May 2019 ## **Objectives** The objects of Erase Meso (EM) are to promote and protect the physical and mental health of existing and future sufferers of Mesothelioma throughout the world through: 1. Provision of financial assistance to scientific research aimed at finding a cure for Mesothelioma and/or controlling the non-financial impact of the disease on existing and future sufferers. 2. Advancement of education and awareness of the general public in all areas relating to Mesothelioma. ## **Governance** EM is a Charitable Incorporated Organisation, established on 1st May 2019, and operating according to a Constitution based on the ‘foundation’ model. The charity trustees, listed above, make all key decisions and are the only voting members of the Organisation. The trustees meet regularly to discuss both operational activities of EM and strategic initiatives and direction ## **Events and Activities** During 2024 the Trustees established a Research Advisory Board to aid with the identification and selection of research projects to fund in line with the EM’s charity’s objectives. In addition, Erase Meso contributed paid out grants of £31,928 to support scientific research into Mesothelioma. Minimal fundraising events and activities took place in 2024, with £4,534 received in donations. ## **Accounts** EM prepare accounts on a receipts and payments basis in line with Charities Commissions requirements. For the period 1st January 2024 to 31st December 2024 funds of £4,534 were raised from events and donations. Payments of £33,627 were deducted, predominantly from £31,928 of grant funding for research into Mesothelioma. The remaining payments of £1,699 related to liability insurance, IT licences and fees deducted by payment and fundraising platforms. EM operates on a volunteer basis, and as such no payments were made for management or advisory services during 2024. Overall excess of payments over receipts was £29,093, reducing cash and equivalents held at balance date. ## **Other** The Trustees would like to express our sincere gratitude to all who have supported EM in our endeavour to raise funds for scientific research and to raise awareness of mesothelioma. Signed on behalf of the Trustees Paul Cook (Trustee) Richard Bath (Trustee) **Erase Meso 1183208 Receipts and payments accounts For the period** 1st January 2024 31st December **To from** **CC16a** ## **Section A Receipts and payments** **Unrestricted Restricted Endowment funds funds funds** ## **Total funds Last year** |**Section A Receipts and payments**
**Unrestricted**
**funds**|**Restricted**
**funds**|**Endowment**
**funds**|**Total funds**|**Last year**| |---|---|---|---|---| |**A1 Receipts**
Donations
**4,534**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**4,534**
**-**
**-**
**_Sub total_ -**
**_Total receipts_ 4,534**
**A3 Payments**
Admin Expenses
**1,699**
Grants
**31,928**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**_Sub total_ 33,627**
**-**
**-**
**_Sub total_ -**
**_Total payments_ 33,627**
**_Net of receipts/(payments)_ - 29,093**
**A5 Transfers between funds**
**-**
**A6 Cash funds last year end**
**168,842**
**_Cash funds this year end_ 139,749**
**to the nearest £**
**_Sub total_**_(Gross income for AR)_
**A2 Asset and investment sales,**
**(see table).**
**A4 Asset and investment**
**purchases,(see table)**|**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**to the nearest £**|**to the nearest £**
**4,534**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**4,534**
**-**
**-**
**-**
**4,534**
**1,699**
**31,928**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**33,627**
**-**
**-**
**-**
**33,627**
**- 29,093**
**-**
**168,842**
**139,749**|**to the nearest £**| |||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**4,534**|**5,040**| ||||**-**|**-**| ||||**-**|**-**| ||||**-**|**-**| ||||**-**|**-**| ||||**-**|**-**| ||||**-**|**-**| ||||**-**|**-**| ||||**4,534**|**5,040**| |||||| |||**-**
**-**
**-**|**-**|| ||||**-**|**-**| ||||**-**|**-**| |||||| |||**-**|**4,534**|**5,040**| |||||| |||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**1,699**|**1,492**| ||||**31,928**|**37,973**| ||||**-**|**-**| ||||**-**|**-**| ||||**-**|**-**| ||||**-**|**-**| ||||**-**|**-**| ||||**-**|**-**| ||||**-**|**-**| ||||**33,627**|**39,465**| |||||| |||**-**
**-**
**-**|**-**|| ||||**-**|| ||||**-**|**-**| |||||| |||**-**|**33,627**|**39,465**| |||||| ||**-**|**-**
**-**
**-**
**-**|**- 29,093**|**- 34,425**| ||**-**||**-**|**-**| ||**-**||**168,842**|**-**| ||**-**||**139,749**|**- 34,425**| ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
**B1 Cash funds**
**B2 Other monetary assets**
**B3 Investment assets**
**B5 Liabilities**
**B4 Assets retained for the**
**charity’s own use**
Signed by one or two trustees on
behalf of all the trustees|**Details**
Bank Account & Equivalents
**Details**
**Details**
**Details**
**Details**
Signature
**_Total cash funds_**
(agree balances with receipts and payments
account(s))|**to nearest £**
**to nearest £**
**139,749**
**-**
**-**
**-**
**-**
**-**
**139,749**
**-**
OK
OK
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
Print Name
Richard Bath
**Unrestricted**
**funds**
**Restricted**
**funds**
**Unrestricted**
**funds**
**Restricted**
**funds**
**Fund to which**
**asset belongs**
**Fund to which**
**asset belongs**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**|**to nearest £**
**Endowment**
**funds**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**to nearest £**
**Endowment**
**funds**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Current value**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**When due**
**(optional)**| ||||| ||||| ||||| ||||| ||||| ||||| ||||Date of
approval| |||Richard Bath|10/31/2024| |||||